Comparison of therapeutic effect between asarone and ambroxol in pediatric asthmatic disease
-
摘要: 目的 探讨细辛脑和沐舒坦在小儿喘息性疾病治疗中的效果.方法 102例小儿喘息性疾病患者随机分为细辛脑组和沐舒坦组,各51例.2组患者均给予常规补液、止咳、化痰、抗感染治疗,细辛脑组,给予细辛脑0.5 mg/kg,1次/d,静脉滴注,连用5～7 d；沐舒坦组,给予沐舒坦0.5～1 mg/kg,喘定10 g/kg,1次/d,静脉滴注,连用5～7d.结果 细辛脑组发热、精神症状、咳嗽、喘息、肺部啰音、气急、紫绀的平均持续天数明显低于沐舒坦组；细辛脑组5d治愈率为74.5％,明显高于沐舒坦组的5d治愈率(54.9％)；细辛脑组治疗5d的总有效率为98.0％,明显高于沐舒坦组的5d总有效率.结论 细辛脑治疗小儿喘息性疾病比沐舒坦见效快、疗效高,但严重过敏体质小儿应慎用.
-
-
Pan G, Zhang S, Feng Y. Air pollution and children's respiratory symptoms in six cities of Northern China [J]. Respiratory Medicine, 2010, (12):1903. Lands L C, Tanswell A K, Laberge S. Pediatric Respiratory Assembly.Mini symposium on lung inflammation [J]. Canadian Respiratory Journal, 2010(2):e35. 马英. 细辛脑治疗喘憋型肺炎患儿42例临床观察 [J]. 临床合理用药杂志, 2012(1):78.doi: 10.3969/j.issn.1674-3296.2012.01.063. 冯益真, 李颖, 董琰. 细辛脑注射液佐治小儿喘息性疾病206例 [J]. 中国民族民间医药, 2008, (10):50.doi: 10.3969/j.issn.1007-8517.2008.10.027. Himmel W, Hummers-Pradier E, Schümann H. The predictive value of asthma medications to identify individuals with asthma-a study in German general practices [J]. British Journal of General Practice, 2001, (472):879. Akkoca Yildiz O. Ambroxol [J]. Tuberk Toraks, 2006, (Suppl 1):3. Gibbs B F. Differential modulation of IgE-dependent activation of human basophils by ambroxol and related secretolytic analogues [J]. International Journal of Immunopathology and Pharmacology, 2009(4):919. 陶爱军, 蔡伟, 张秀伟. 支气管哮喘急性发作期血清降钙素原水平的临床意义 [J]. 实用临床医药杂志, 2011, (23):123.doi: 10.3969/j.issn.1672-2353.2011.23.050. 张卫珍, 赵海金, 邹飞. Slingshot-1L在哮喘急性发作期外周血嗜酸粒细胞中的定位与表达变化 [J]. 南方医科大学学报, 2011(6):928.
计量
- 文章访问数: 168
- HTML全文浏览量: 48
- PDF下载量: 5
下载:
苏公网安备 32100302010246号
